Clinical findings of a myoclonus-dystonia family with two distinct mutations
- 22 October 2002
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 59 (8) , 1244-1246
- https://doi.org/10.1212/wnl.59.8.1244
Abstract
Myoclonus-dystonia has recently been associated with mutations in the epsilon-sarcoglycan gene (SCGE) on 7q21. Previously, the authors reported a patient with myoclonus-dystonia and an 18-bp deletion in the DYT1 gene on 9q34. The authors have now re-evaluated the patient harboring this deletion for mutations in the SGCE gene and identified a missense change. In the current study, the authors describe the clinical details of this family carrying mutations in two different dystonia genes. Further analysis of these mutations separately and together in cell culture and in animal models should clarify their functional consequences.Keywords
This publication has 8 references indexed in Scilit:
- Book ReviewHormone Research in Paediatrics, 2002
- Myoclonus dystoniaNeurology, 2002
- Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndromeNature Genetics, 2001
- Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonismneurogenetics, 2001
- A major locus for several phenotypes of myoclonus–dystonia on chromosome 7qNeurology, 2001
- Redesign of PNAS: New Covers for the JournalProceedings of the National Academy of Sciences, 1999
- Dystonia in Ashkenazi Jews: Clinical characterization of a founder mutationAnnals of Neurology, 1994
- Diagnostic Interview for Genetic StudiesArchives of General Psychiatry, 1994